Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells

Gallic acid: Molecular rival of cancer

(2013) Sharad Verma et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Epidermal growth factor receptor as a biomarker for cervical cancer

(2011) T. Soonthornthum et al.   ANNALS OF ONCOLOGY

Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells

(2011) Ji-Hak Jeong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway

(2011) Ping Lin et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion

(2011) Bo Ra You et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Loss of Estrogen Receptor 1 Enhances Cervical Cancer Invasion

(2010) Yali Zhai et al.   AMERICAN JOURNAL OF PATHOLOGY

ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation

(2010) Xuguang Zheng et al.   CANCER BIOLOGY & THERAPY

Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis

(2010) Bo Ra You et al.   FOOD AND CHEMICAL TOXICOLOGY

Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase

(2010) Bo Ra You et al.   TOXICOLOGY IN VITRO

ADAM Proteins- Therapeutic Potential in Cancer

(2008) Xinjie Lu et al.   CURRENT CANCER DRUG TARGETS

Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice

(2008) K. Raina et al.   MOLECULAR CANCER THERAPEUTICS